ACRO Biomedical Co., Ltd. (TPEX:6748)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.10
+0.60 (0.81%)
Sep 4, 2025, 1:55 PM CST
0.81%
Market Cap4.61B
Revenue (ttm)44.23M
Net Income (ttm)-62.09M
Shares Out61.22M
EPS (ttm)-1.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume202,136
Average Volume846,670
Open74.20
Previous Close74.50
Day's Range74.20 - 76.80
52-Week Range22.35 - 94.30
Beta0.73
RSI51.61
Earnings DateAug 11, 2025

About ACRO Biomedical

ACRO Biomedical Co., Ltd. develops medical-grade regenerative biomaterials. The company offers products in the areas of wound care, orthopedics, dentistry, ophthalmology, cosmetic micro plastic surgery, beauty and eye care, and tissue engineering and regenerative medicines. ACRO Biomedical Co., Ltd. was founded in 2014 and is based in Kaohsiung, Taiwan. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2014
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6748
Full Company Profile

Financial Performance

In 2024, ACRO Biomedical's revenue was 44.23 million, a decrease of -13.38% compared to the previous year's 51.06 million. Losses were -62.09 million, 49.9% more than in 2023.

Financial Statements

News

There is no news available yet.